161 related articles for article (PubMed ID: 37713125)
1. The experience of diagnosis and treatment for TAFRO syndrome.
Wu X; Zhang X; Qian S; Shi C; Li X; Feng X; Zhu L; Ge J; Li Z; Zhang M
Ann Hematol; 2023 Dec; 102(12):3515-3520. PubMed ID: 37713125
[TBL] [Abstract][Full Text] [Related]
2. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
3. High proportion of TAFRO syndrome in Thai adult Castleman's disease patients: a 10-year experience.
Owattanapanich W; Pholmoo W; Pongpruttipan T; Siritanaratkul N
Ann Hematol; 2018 Jun; 97(6):1019-1026. PubMed ID: 29464312
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.
Zhang Y; Suo SS; Yang HJ; Zhou XP; You LS; Yu WJ; Wang ZM; Jin J
J Cancer Res Clin Oncol; 2020 Feb; 146(2):357-365. PubMed ID: 31938902
[TBL] [Abstract][Full Text] [Related]
5. TAFRO Syndrome That Responded to Prednisolone-only Treatment: Evaluating Changes in IL-6.
Suzuki H; Sano T; Shimasaki Y; Yamaguchi M; Ide T; Arinaga-Hino T; Kuwahara R; Amano K; Oshima K; Nagafuji K; Ida H; Koga H; Torimura T
Intern Med; 2022 Oct; 61(19):2967-2972. PubMed ID: 35228431
[TBL] [Abstract][Full Text] [Related]
6. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
[TBL] [Abstract][Full Text] [Related]
7. [Successful rituximab treatment of TAFRO syndrome refractory to glucocorticoids and tocilizumab].
Sumi C; Toki Y; Funayama T; Saito T; Hatayama M; Yamamoto M; Shindo M; Yuzawa S; Tanino M; Okumura T
Rinsho Ketsueki; 2023; 64(4):265-270. PubMed ID: 37121770
[TBL] [Abstract][Full Text] [Related]
8. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
Sakai K; Maeda T; Kuriyama A; Shimada N; Notohara K; Ueda Y
Mod Rheumatol; 2018 May; 28(3):564-569. PubMed ID: 26886414
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
[TBL] [Abstract][Full Text] [Related]
10. Sjögren's syndrome manifesting as clinicopathological features of TAFRO syndrome: A case report.
Fujimoto S; Kawabata H; Kurose N; Kawanami-Iwao H; Sakai T; Kawanami T; Fujita Y; Fukushima T; Masaki Y
Medicine (Baltimore); 2017 Dec; 96(50):e9220. PubMed ID: 29390349
[TBL] [Abstract][Full Text] [Related]
11. [TAFRO syndrome and cutaneous necrotizing vasculitis].
Maquet J; Bories E; Nogier MB; Beck C; Aizel G; Toledano A; Faguer S; Paricaud K; Pugnet G; Moulis G; Astudillo L; Sailler L
Rev Med Interne; 2021 Feb; 42(2):134-139. PubMed ID: 33218790
[TBL] [Abstract][Full Text] [Related]
12. A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.
Takasawa N; Sekiguchi Y; Takahashi T; Muryoi A; Satoh J; Sasaki T
Mod Rheumatol; 2019 Jan; 29(1):198-202. PubMed ID: 27413814
[TBL] [Abstract][Full Text] [Related]
13. TAFRO syndrome: A disease that known is half cured.
Chen T; Feng C; Zhang X; Zhou J
Hematol Oncol; 2023 Aug; 41(3):310-322. PubMed ID: 36148768
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort.
Maisonobe L; Bertinchamp R; Damian L; Gérard L; Berisha M; Guillet S; Fieschi C; Malphettes M; Fadlallah J; Hié M; Dunogué B; De Wilde V; Vandergheynst F; Zafrani L; Grall M; Saada N; Garzaro M; Oksenhendler E; Galicier L; Boutboul D
Br J Haematol; 2022 Feb; 196(3):599-605. PubMed ID: 34585382
[TBL] [Abstract][Full Text] [Related]
15. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
[TBL] [Abstract][Full Text] [Related]
16. TAFRO syndrome with fatigue and abdominal distension as the first symptom: A case report.
Zhou B; Tang C; Chen G; Jiang T; Shi X; Wang F
Hematol Oncol; 2023 Apr; 41(2):285-290. PubMed ID: 34997628
[TBL] [Abstract][Full Text] [Related]
17. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
Fujiwara Y; Ito K; Takamura A; Nagata K
J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
[TBL] [Abstract][Full Text] [Related]
18. [Clinical Anslysis of TAFRO Syndrome].
Liu F; Wei XF; Feng YF; Fu Y; Chen QL; Chen Y; Zhang QK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1872-1877. PubMed ID: 38071075
[TBL] [Abstract][Full Text] [Related]
19. TAFRO syndrome is associated with anti-SSA/Ro60 antibodies, in contrast to idiopathic castleman disease.
Shirakashi M; Nishida Y; Nakashima R; Fujimoto M; Hiwa R; Tsuji H; Kitagori K; Akizuki S; Morinobu A; Yoshifuji H
Sci Rep; 2024 Feb; 14(1):2889. PubMed ID: 38311632
[TBL] [Abstract][Full Text] [Related]
20. TAFRO Syndrome.
Igawa T; Sato Y
Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]